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Abstract In forensic science, the unequivocal identifica-
tion of the cellular origin of crime scene samples used for
DNA profiling can provide crucial information for crime
scene reconstruction. We have previously shown that
various mRNA markers from genes with expression
patterns specific for blood and saliva can be established
from whole-genome expression analysis of time-wise
degraded samples and were stable enough to specifically
identify blood and saliva stains up to 180 days of age. Here,
we showed that nine blood-specific and five saliva-specific
mRNA markers can be amplified successfully and reliably
in much older blood (13–16 years) and saliva (2–6 years)
stains, respectively, suggesting their suitability for tissue
identification in forensic case work. Moreover, our findings
imply that forensic RNA testing can be reliable and robust
if degraded samples are considered in the marker ascertain-
ment procedure, with promising expectations beyond tissue
identification purposes.
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Introduction
The reliable identification of the cellular origin of crime
scene samples used for DNA profiling can potentially pro-
vide crucial information for crime scene reconstruction.
Although RNA is generally believed to be highly unstable
and prone to degradation due to the action of ribonucleases
and environmental factors such as pH, UV light, and mois-
ture [1], recent advances in molecular forensics revealed a
number of RNA markers successfully amplifiable under
certain postmortem and/or in vitro conditions [2–6]. For
instance, Karlsson et al. [7] detected mRNA from the
β-actin and GAPDH genes in 27-year-old blood stains;
however, the study design did not ensure that polymerase
chain reaction (PCR) amplification products truly origi-
nated from cDNA templates and not from contaminating
genomic DNA. We have previously shown that various
mRNA markers from genes with expression patterns spe-
cific for blood and saliva can be established from whole-
genome expression analysis of time-wise degraded samples,
and respective mRNA markers were able to specifically
identify blood and saliva stains of up to 180 days of age [8].
In the present study, we tested the behavior of the pre-
viously identified mRNA markers in much older blood and
saliva stains as prerequisite for future application to
forensic case work. Empirical testing of mRNA marker
stability is essential because usually the age of a crime
scene sample is originally unknown. Therefore, and in
prerequisite for practical forensic applications, it needs to
be proven that the particular mRNA markers intended for
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forensic use can be amplified successfully under a wide
range of sample conditions including sample age.
Materials and methods
Blood and saliva samples were collected from nine and 12
healthy volunteers of Western European origin, respec-
tively, under their informed consent. Blood was spotted
onto a clean cotton tissue and saliva was collected by absorp-
tion with cotton or cellulose swabs. Prior to RNA isolation,
dried specimens were stored at ambient temperature in dust-
free, nonhumid conditions (subjected to normal daylight)
for 13–16 and 2–6 years for blood and saliva stains,
respectively. Pieces of blood-stained cotton tissue used for
RNA extraction ranged in size from ~0.05 to ~0.75 cm2; in
case of saliva samples, an amount of material equivalent to
one standard cotton swab was used. Total RNA isolation was
performed with QIAGEN RNeasy Mini Kit (QIAGEN
Benelux B.V., Netherlands) according to the manufacturer’s
instructions with minor modifications as described previ-
ously [8]. RNA extracts were treated with Turbo DNase
kit from Ambion (Applied Biosystems, Netherlands). The
quality and quantity of RNA was assessed by capillary
electrophoresis on Agilent 2100 Bioanalyzer automated anal-
ysis system (Agilent Technologies, Palo Alto, CA, USA).
Complementary DNA synthesis was carried out with Invi-
trogen SuperScript® III First Strand Synthesis System for
reverse-transcriptase (RT)-PCR (Invitrogen BV, Netherlands)
using random hexamer primers according to manufacturer’s
instructions. Reactions without addition of reverse tran-
scriptase (RT(−) controls) were performed alongside with
cDNA synthesis of each sample and used in subsequent
procedures to control the potential genomic DNA contam-
ination. Real-time PCR reactions with the Platinum SYBR
Green qPCR Kit (Invitrogen BV, Netherlands) were per-
formed in 15-μL reaction volume in triplicates on ABI 7300
PCR machine (Applied Biosystems, Netherlands) using
previously described oligonucleotide primers for nine genes
with blood-specific expression pattern (ALOX5AP, AMICA1,
AQP9, ARHGAP26, C1QR1, C5R1, CASP1, MNDA, and
NCF2) and for five genes with saliva-specific expression
pattern (SPRR1A, SPRR2A, KRT4, KRT6A, and KRT13)
[8]. The following cycling parameters were used during
PCR: initial denaturation at 94°C for 10 min, followed by
45 cycles of denaturation at 94°C for 15 s, and a final
annealing–elongation at 60°C for 30 s. Melting profiling
and agarose gel electrophoresis were used to confirm the
specificity of the amplification. Messenger RNA markers
were additionally tested in cDNA from 2-year-old blood
samples that was derived from random hexamer primers,
oligo(dT)20 primers, and gene-specific primers, respective-
ly, to test for sensitivity effects of the reverse-transcription
technique in respect of the mRNA markers tested. All three
reverse-transcription methods allowed successful amplifi-
cation of all mRNA markers and on a similar level of
sensitivity (data not shown). However, experimental repro-
ducibility was slightly better for cDNA produced by
random hexamer primers compared to gene-specific or
oligo(dT)20 primers (data not shown) so that we decided to
apply random hexamer primers for cDNA synthesis in this
study.
Results and discussion
In spite of the severe RNA degradation (see Supplementary
Fig. S1), we were able to obtain PCR products ranging in
length from 93 to 195 bp from cDNA of all genes analyzed
in old blood and saliva stains (Fig. 1a, b). RT(−) controls
were negative in all cases and the size of the PCR
amplicons revealed corresponded for all genes to the
intronless cDNA templates providing strong evidence for
the absence of genomic DNA contamination. The experi-
mental setup included approximate estimation of the
marker’s detection sensitivity relative to the starting amount
of bloodstain material. According to Agilent 2100 Bio-
analyzer measurements, 0.5–1.0 ng of total RNA was
yielded from ~0.75 cm2 of bloodstain. After cDNA
synthesis, this amount was divided into an equal number of
aliquots to perform 45 PCRs (three replicates × nine genes +
Fig. 1 Agarose gel electrophoresis of PCR products from a nine
mRNA markers with blood-specific expression pattern as obtained
from RNA extracted from a 13–16-year-old bloodstain with lanes 1–9
corresponding to mRNA markers from the following genes: CASP1,
AMICA1, C1QR1, ALOX5AP, AQP9, C5AR1, ARHGAP26, NCF2,
and MNDA, respectively, and b five mRNA markers with saliva-
specific expression pattern as obtained from RNA extracted from a
6-year-old saliva stain with lanes 1–5 corresponding to mRNA markers
from the following genes: KRT4, KRT6A, KRT13, SPRR1A, and
SPRR2A, respectively. Lane M corresponds to a molecular-size ladder
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no template and RT(−) control reactions for each gene), i.e.,
each reaction contained the amount of template equivalent to
as little as ~16 pg of RNA. RT-PCR threshold cycle (Ct)
values were in the range of 28.8–34.3 for different blood-
specific mRNA markers tested and a high rate of successful
amplification was observed (Table 1). Reproducibility
between individual samples was 100% for all mRNA
markers and reproducibility within individuals among three
technical replicates was 100% for five mRNA markers and
90% for four (Table 1). The experiments with the blood-
stains of much smaller size of ~0.05 cm2 were carried out in
a similar manner. However, in this case, RNA was not
quantified because of the expected subpicogram yield,
which is far below the detection limit of the device used
for quantification. As expected, decreasing the starting
amount of material significantly reduced the success rate of
PCR amplifications: no PCR products were obtained
anymore for three markers (ALOX5AP, AQP9, and C5R1),
whereas the other markers, showed higher Ct values (30.9–
34.6) and less reproducibility between (70–100%) as well
as within (40–80%) individuals compared with the tests
from larger blood stains for the respective markers (Table 1).
However, at least one blood-specific mRNA marker
(NCF2), which showed the lowest Ct value of all markers
in the large and small stain analyses, could be detected from
the small-sized blood stains of ~0.05 cm2 with 100%
between-individual and 80% within-individual reproduc-
ibility. Results derived from the ~0.05-cm2 blood stains
indicate that the amount of RNA in the samples was at the
limit of the sensitivity of the applied regular PCR-based
detection method (perhaps with the exception of NCF2).
The yield of total RNA from old saliva stains was in a
range of 50–200 ng per sample. The amount of cDNA
template used in individual PCR reactions was equivalent



















NCF2 28.8 1.0 100 100 30.9 1.4 100 80
MNDA 29.9 1.0 100 100 33.0 2.0 80 60
CASP1 33.0 1.2 100 90 33.9 1.1 80 60
C1QR1 32.1 1.6 100 90 34.5 0.7 70 40
ARHGAP26 33.7 0.8 100 100 34.6 0.5 80 60
AMICA1 31.7 1.1 100 100 33.0 0.8 80 40
ALOX5AP 34.3 3.4 100 90 – – – –
AQP9 32.9 1.1 100 100 – – – –
C5R1 32.0 1.0 100 90 – – – –
aBased on RNA was extracted from 0.75-cm2 blood stains
bReproducibility between individuals was defined as the percentage of successful amplifications in at least one of three technical replicates
averaged across all nine individuals tested
cReproducibility within individuals was defined as the percentage of successful amplification in three technical replicate RT-PCRs for the same
individual averaged across all nine individuals tested; a Kruskal–Wallis test identified no outliers in the reproducibility of technical replicates with
p<0.05, i.e., variation among RT-PCR replicates was random
dBased on RNA was extracted from 0.05-cm2 blood stains
Table 2 Results of RT-PCR amplification of mRNA markers from genes with saliva-specific expression pattern in stains of 2–6 years of age




KRT4 28.3 3.6 90 90
KRT6A 31.5 3.8 100 80
KRT13 28.6 3.6 100 90
SPRR1A 31.3 2.3 100 100
SPRR2A 29.7 2.7 100 90
a Reproducibility between individuals was defined as the percentage of successful amplifications in at least one of three technical replicates
averaged across all 12 individuals tested
b Reproducibility within individuals was defined as the percentage of successful amplification in three technical replicate RT-PCRs for the same
individual averaged across all 12 individuals tested; a Kruskal–Wallis test identified no outliers in the reproducibility of technical replicates with
p<0.05, i.e., variation among RT-PCR replicates was random
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to ~25 ng of total RNA (25 individual reactions from one
sample). RT-PCR Ct values for saliva-specific mRNA
markers were in the range of 28.3–31.5 (Table 2), which
is similar to the analysis of blood-specific markers from the
0.75-cm2 stains but with higher standard deviations.
Reproducibility between individuals was high (100% for
four markers and 90% for one) but slightly more variable
(80–100%) within individuals (Table 2). It is worth noting
that, although Ct values were comparable, the amount of
total RNA was about 1,500× higher in the saliva analyses
compared with the 0.75-cm2 blood stain analyses.
Over all, we expect the achieved mRNA marker
sensitivities, which were higher for blood-specific mRNA
markers (picogram range of total RNA) than for saliva-
specific ones (nanogram range of total RNA), matching the
demands of most forensic cases requiring blood and saliva
identification from crime scene samples. Although techni-
cal modifications like alternative primer design, nested PCR,
or RNA amplification prior to PCR might further increase
the test sensitivity, the latter two also bear extra risks of
contamination-induced artifacts that need to be avoided.
To conclude, our present data together with those from
our previous study [8] demonstrate that nine mRNA
markers with blood-specific expression pattern (ALOX5AP,
AMICA1, AQP9, ARHGAP26, C1QR1, C5R1, CASP1,
MNDA, and NCF2) and five mRNA markers with saliva-
specific expression (SPRR1A, SPRR2A, KRT4, KRT6A, and
KRT13) are sufficiently stable and sensitive to enable the
detection of blood and saliva in samples of a wide age
range, from freshly dried up to at least 16 and 6 years of
age for blood and saliva stains, respectively. This provides
sufficient evidence in favor of their application to forensic
cases involving stains of unknown age, at least those kept
under similar environmental conditions as applied here.
However, additional environmental factors such as humid-
ity and UV radiation, which could potentially influence in
vitro mRNA marker stability in addition to sample age,
require further investigation. We additionally showed that
the detection limit for our blood-specific mRNA markers
was significantly lower than that of our saliva-specific
markers suggesting that the cellular origin of biological
stains might be a considerable factor (amongst others)
influencing RNA stability. Many pathophysiological con-
ditions but also human-visible traits that are potentially
useful for death–trauma examination or suspect–victim
identification in forensics are associated with gene expres-
sion changes. Therefore, the use of biological stains as a
source of stable mRNA markers for transcription analysis in
forensic and medico-legal investigations opens prospects
that lie far beyond the tissue identification purpose
presented here.
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